Prostate Cancer

Pathologists and laboratory professionals are key members of the multidisciplinary cancer care team, with roles in the diagnosis, testing, and management of diseases such as prostate cancer. As new evidence continues to emerge related to personalized testing, treatment, and reporting, ASCP is dedicated to helping you stay abreast of new findings to ensure accurate diagnoses and improve the standard of care for patients with prostate cancer.

NGS Testing for DNA Repair Gene Mutations in Prostate Cancer

This course is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team. This course highlights NGS testing and reporting in prostate cancer, course topics include:

  • Advantages of NGS testing and reporting in prostate cancer
  • Strategies to effectively test for homologous recombination repair mutations in prostate cancer
  • Considerations for NGS adoption, including:
    • Specimen quality/adequacy and testing
    • Potential pitfalls
    • Available diagnostic tests for HRR mutations
    • NGS reporting considerations
  • Importance of partnering with the multidisciplinary cancer care team to utilize NGS testing for patients with prostate cancer

This activity is funded by an independent educational grant from Pfizer and provides .50 CME/CMLE credit.

Register Now

Your Role in Precision Management of Advanced Prostate Cancer: Molecular Testing and HRR-deficiency

This course is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team. This course highlights advances in biomarker testing for prostate cancer, course topics include: 

  • Updates in biomarker testing, with a focus on HRR mutations
  • Prevalence/prognosis
    • Poor outcomes for misdiagnosed/underdiagnosed patients
  • Importance
  • Clinical practice guidelines
  • Multidisciplinary care team communication and collaboration

This activity is funded by an independent educational grant from Pfizer and provides .25 CME/CMLE credit.

Register Now
Podcast

Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer

This podcast highlights HRR testing in prostate cancer and the need for testing and optimal testing. The discussion features an expert pathologist and oncologist.

This activity is funded by an independent educational grant from Pfizer and provides .25 CME/CMLE credit.

Listen Now
Infographic

Biomarker Testing in Prostate Cancer

This infographic highlights biomarker testing in prostate cancer. Topics include:

  • Clinical algorithm for genetic testing
  • Flow of sample during genetic testing
  • Approved combinations and indications
  • Optimal testing technique
  • Reporting

This activity is funded by an independent educational grant from Pfizer.

Download Infographic (pdf)